1. Home
  2. BAK vs BHVN Comparison

BAK vs BHVN Comparison

Compare BAK & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braskem SA ADR

BAK

Braskem SA ADR

HOLD

Current Price

$2.93

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.10

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAK
BHVN
Founded
1972
2013
Country
Brazil
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
BAK
BHVN
Price
$2.93
$11.10
Analyst Decision
Hold
Buy
Analyst Count
2
15
Target Price
$4.40
$29.79
AVG Volume (30 Days)
784.0K
2.8M
Earning Date
11-11-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,841,708,237.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.81
$1,147.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$7.48
52 Week High
$5.10
$44.28

Technical Indicators

Market Signals
Indicator
BAK
BHVN
Relative Strength Index (RSI) 51.52 53.32
Support Level $2.78 $8.50
Resistance Level $3.13 $11.80
Average True Range (ATR) 0.12 0.91
MACD -0.00 0.08
Stochastic Oscillator 51.09 81.83

Price Performance

Historical Comparison
BAK
BHVN

About BAK Braskem SA ADR

Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: